Search results
Showing 2501 to 2550 of 3030 results for all
at particularly high risk and that oral hydration should be encouraged in all other adults at increased risk of contrast-induced acute...
they are properly implemented. The committee agreed that it is important for all sizes of organisation to clearly communicate policies...
Early value assessment (EVA) guidance on CaRi-Heart for predicting cardiac risk in suspected coronary artery disease.
This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.
Evidence-based recommendations on daratumumab (Darzalex) with bortezomib, thalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is suitable.
ClearWay RX for drug delivery to coronary artery thrombotic lesions (MIB55)
NICE has developed a medtech innovation briefing (MIB) on ClearWay RX for drug delivery to coronary artery thrombotic lesions
attitudes and reducing stereotyping may result in people working for longer, with all the associated benefits for them and society....
What is the best way of monitoring the local system for distributing vitamin D supplements?
adherence or any unintentional consequences. The recommendations apply to all at-risk groups, but there is a particular need for...
NICE has developed a medtech innovation briefing (MIB) on the needle-free arterial non-injectable connector .
U-Drain for people needing night drainage of urine or dialysis fluid (MIB95)
NICE has developed a medtech innovation briefing (MIB) on U-Drain for people needing night drainage of urine or dialysis fluid .
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events (HTG325)
Evidence-based recommendations on percutaneous closure of the patent foramen ovale for the prevention of cerebral embolic stroke. This involves placing a small device into the heart to close the hole.
landlords, and those who regulate them.Similarly, the committee agreed that not all professionals who see people in their home know who...
Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults.
Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (TA897)
Evidence-based recommendations on daratumumab (Darzalex) with bortezomib and dexamethasone for previously treated multiple myeloma in adults.
Voclosporin with mycophenolate mofetil for treating lupus nephritis (TA882)
Evidence-based recommendations on voclosporin (Lupkynis) with mycophenolate mofetil for treating lupus nephritis in adults.
Cladribine for treating active relapsing forms of multiple sclerosis (TA1053)
Evidence-based recommendations on cladribine (Mavenclad) for treating active relapsing forms of multiple sclerosis in adults.
Evidence-based recommendations on palbociclib (Ibrance) as initial endocrine-based therapy for hormone-receptor positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic (secondary) breast cancer in adults.
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
guidance Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain Number...
adherence or any unintentional consequences. The recommendations apply to all at-risk groups, but there is a particular need for...
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)
Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 2 diabetes mellitus to inform local NHS planning and decision-making
Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available.
Community pharmacies: promoting health and wellbeing (QS196)
This quality standard covers how community pharmacies can support the health and wellbeing of the local population. It describes high-quality care in priority areas for improvement.
View quality statements for QS196Show all sections
Sections for QS196
This quality standard covers diagnosing and managing spondyloarthritis in adults aged 16 and over. It describes high-quality care in priority areas for improvement.
This quality standard covers increasing the uptake of flu vaccination among people who are eligible. It describes high-quality care in priority areas for improvement.
This quality standard covers the diagnosis and initial management of ectopic pregnancy and miscarriage in women, trans men and non-binary people in their first trimester (up to 13 completed weeks of pregnancy). It includes assessment and diagnosis for people with suspected early pregnancy loss. It describes high-quality care in priority areas for improvement.
View quality statements for QS69Show all sections
Sections for QS69
- Quality statements
- Quality statement 1: Timely referral to early pregnancy assessment services
- Quality statement 2: Ultrasound to identify miscarriage or tubal ectopic pregnancy
- Quality statement 3: Confirming a diagnosis of miscarriage
- Quality statement 4: Anti-D immunoglobulin prophylaxis (up to and including 11+6 weeks of pregnancy)
- Update information
- About this quality standard
I: Inhaled budesonide C: Inhaled placebo (to accommodate blinding) O:• All-cause mortality• Hospitalisation• Need for oxygen therapy...
What is the clinical and cost effectiveness of preoperative optimisation clinics for older people?
identified during the preoperative assessment. These clinics are not available in all areas and are expensive to establish. Although a...
identified during the preoperative assessment. These clinics are not available in all areas and are expensive to establish. Although a...
LMWH C: standard prophylaxis with LMWH O:• incidence of VTE• mortality (all-cause, inpatient, COVID-19 related)• admission to critical...
Early value assessment (EVA) guidance on point-of-care tests for urinary tract infections to improve antimicrobial prescribing.
Any explanatory notes(if applicable) Why this is important:- Virtually all patients self-manage their condition to a greater or lesser...
is uncertainty about the clinical benefit of warming patients and whether all groups of patients would benefit from warming. In...
Assessing the severity of lung disease is difficult in younger children. Not all children under 5 years can do spirometry tests and they...
adherence or any unintentional consequences. The recommendations apply to all at-risk groups, but there is a particular need for...
Health Technology Assessment Innovation Laboratory (HTA Lab)
NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.
identified during the preoperative assessment. These clinics are not available in all areas and are expensive to establish. Although a...
Digitally enabled therapies for adults with depression: early value assessment (HTG675)
Early value assessment (EVA) guidance on digitally enabled therapies for adults with depression.
extended pharmacological VTE prophylaxis O:• incidence of VTE• mortality (all-cause, inpatient, COVID-19 related)• serious adverse...
attempt to obtain data on pharmaco-resistance the possibility of including all children with specific epilepsy syndromes for...
risk factors for falling in the inpatient setting, but these studies are not all relevant to a current UK hospital population....